 ROCKVILLE, Md., Feb. 24, 2021 PRNewswire -- RegeneRx Biopharmaceuticals, Inc. OTCQB: RGRX the Company or RegeneRx, a clinical-stage biopharmaceutical company focused on tissue protection, repair and regeneration, announced that the ARISE-3 Phase 3 clinical trial database... 